GBA1 and Parkinson disease: In a recent study employing the same paradigm as used here, dissociable signature deficits associated with glucocerebrosidase (GBA) mutations—the highest known genetic risk factor for developing Parkinson’s disease—and sporadic Parkinson’s disease were reported (Zokaeiet al., 2014).